The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:

Notices

• Notice Announcing the Removal of the Funding Pause for Gain-of-Function Research Projects 
  National Institutes of Health
• Maintaining Integrity in NIH Peer Review: Responsibilities and Consequences
  National Institutes of Health
• Revision: NIH Policy and Guidelines on the Inclusion of Individuals Across the Lifespan as Participants in Research Involving Human Subjects
  National Institutes of Health
• NIH Operates Under a Continuing Resolution Through December 22, 2017
  National Institutes of Health
• FINDINGS OF RESEARCH MISCONDUCT
  National Institutes of Health
• Notice of Change to Award Information in RFA-AI-17-040 "Cooperative Centers on Human Immunology (U19 Clinical Trial Optional"
  National Institute of Allergy and Infectious Diseases
• Notice of Participation of National Institute of Allergy and Infectious Diseases (NIAID) on PAR-18-333" Understanding the Early Development of the Immune System (R01 - Clinical Trial Not Allowed)"
  National Institute of Allergy and Infectious Diseases
• Notice of NIAMS' Participation in PA-18-375 "Mentored Patient-Oriented Research Career Development Award (Parent K23 -Independent Clinical Trial Not Allowed)"
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
• Notice of NIAMS' Participation in PA-18-394 " Midcareer Investigator Award in Patient-Oriented Research (Parent K24 - No Independent Clinical Trials)"
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
• Notice of Correction to Key Dates for PAR-18-022 "Tobacco Use and HIV in Low and Middle Income Countries (R21 Clinical Trial Optional)"
  National Cancer Institute
• NIH Applicant Assistance Program (AAP) for New or Previously Unawarded Small Businesses
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute of Neurological Disorders and Stroke
• Notice of Correction to PA-18-517, "Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp - Clinical Trial Not Allowed)"
  National Cancer Institute
• Notice of NIDDK's Participation in PAR-18-189 "Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)"
  National Institute of Diabetes and Digestive and Kidney Diseases
• Notice of NIDDK's Participation in PAR-18-190 "Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)"
  National Institute of Diabetes and Digestive and Kidney Diseases
• Notice to Clarify the Types of Clinical Trials NIBIB Will Supported Under PAR-18-208 Bioengineering Research Partnerships (U01 Clinical Trial Optional)
  National Institute of Biomedical Imaging and Bioengineering
• Notice of Participation of the National Institute of Environmental Health Sciences in PA-18-397 "NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Required"
  National Institute of Environmental Health Sciences
• Notice of Participation of the National Institute of Environmental Health Sciences in PA-18-395 "Mentored Quantitative Research Development Award (Parent K25 - Clinical Trial Required)"
  National Institute of Environmental Health Sciences
• Notice of NEI Participation in PAR-18-501 "BRAIN Initiative: Development, Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (SBIR)(R43/R44 Clinical Trial Not Allowed)"
  National Eye Institute
• Notice of NEI Participation in PAR-18-515 "BRAIN Initiative: Development, Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (STTR)(R41/R42 Clinical Trial Not Allowed)"
  National Eye Institute
• Notice of Correction to Eligibility Information in PAR-17-190 "Maximizing Investigators' Research Award for Early Stage Investigators (R35)"
  National Institute of General Medical Sciences
• Notice of Changes in PAR-16-149 "Archiving and Documenting Child Health and Human Development Data Sets (R03)"
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 
• Notice of NIMHD Participation in RFA-HL-19-007 "Limited Competition: Data Analysis and Coordination Center for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) (U01 Clinical Trial Not Allowed)"
  National Institute on Minority Health and Health Disparities 
• Notice of NIMHD Participation in RFA-HL-19-008 "Limited Competition: Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) (U01 Clinical Trial Not Allowed)"
  National Institute on Minority Health and Health Disparities 
• Notice of NINDS Policy for Submission of Applications and Participation in PA-18-345 "NIH Research Project Grant (Parent R01) - Clinical Trial Required". NINDS Only accepts Clinical Trial Applications Proposing Mechanistic Studies for Clinical Trial Parent R01
  National Institute of Neurological Disorders and Stroke
• Notice of Clarification of NINDS Statement of interest for "Bioengineering Research Partnerships (BRP) (U01 Clinical Trial Optional)"
  National Institute of Neurological Disorders and Stroke
• Notice of NINDS Withdrawal from Participation in PA-18-286 "Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)"
  National Institute of Neurological Disorders and Stroke
• Notice of Pre-Application Webinar for the Common Fund Human Biomolecular Atlas Program (HuBMAP) RFAs (RFA-RM-17-025, RFA-RM-17-027)
  The Common Fund/Office of Strategic Coordination
• Notice of Change to Receipt Date on NIH-CASIS Coordinated Microphysiological Systems Program for Translational Research in Space (UG3/UH3 Clinical Trials Not Allowed) (RFA-TR-18-001)
  National Center for Advancing Translational Sciences

Requests for Applications

• Understanding the Effects of ApoE2 on the Interaction between Aging and Alzheimers Disease (R01 - Clinical Trial Not Allowed)
  National Institute on Aging
    
• Consequences of amyloid protein polymorphisms in Alzheimer's disease (R01 - Clinical Trial Not Allowed)
  National Institute on Aging
   
• Improving Implementation of Seek, Test, Treat and Retain Strategies among People Who Inject Drugs in Low to Middle Income Countries (R01-Clinical Trial Required)
  National Institute on Drug Abuse
    
• Identification of Biomarkers of HIV-1 Pathogenesis and Substance Abuse Comorbidity (R01- Clinical Trial Not Allowed)
  National Institute on Drug Abuse
    
• Ancillary Studies to the NIDDK Inflammatory Bowel Disease Genetics Consortium (R01- Clinical Trial Optional)
• Ancillary Studies to the NIDDK Inflammatory Bowel Disease Genetics Consortium (R21 - Clinical Trial Optional)
  National Institute of Diabetes and Digestive and Kidney Diseases
   
• Support for Small Business Innovation Research to Develop New Open and Closed-Loop Automated Technologies for Better Type 1 Diabetes Therapy and Monitoring (SBIR) (R43/R44- Clinical Trial Not Allowed)
  National Institute of Diabetes and Digestive and Kidney Diseases
   
• Development of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (R43/44 Clinical Trial Not Allowed)
  National Institute of Diabetes and Digestive and Kidney Diseases
   
• Limited Competition: Data Analysis and Coordination Center for the MACS/WIHS Combined Cohort Study, MACS/WIHS-CCS (U01 Clinical Trials Not Allowed)
• Limited Competition: Clinical Research Sites for MACS/WIHS Combined Cohort Study, MACS/WIHS-CCS (U01-Clinical Trials Not Allowed)
  National Heart, Lung, and Blood Institute
  National Cancer Institute
  National Human Genome Research Institute
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities 
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
   
• BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 - Clinical Trial Required)
• BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (U44 Clinical Trial Required)
• BRAIN Initiative: Clinical Studies to Advance Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UH3 - Clinical Trial Required)
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Mental Health
    
•  Transformative Technology Development for the Human BioMolecular Atlas Program (UG3/UH3 Clinical Trials Not Allowed)
• Tissue Mapping Centers for the Human BioMolecular Atlas Program (U54 Clinical Trials Not Allowed)
  The Common Fund/Office of Strategic Coordination
    

Program Announcements

• Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R21 Clinical Trial Optional)
• Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R01 Clinical Trial Optional)
• Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R15 Clinical Trial Not Allowed)
  National Institute of Nursing Research
  National Institute on Aging
    
• Self-Management for Health in Chronic Conditions (R01 Clinical Trial Optional)
• Self-Management for Health in Chronic Conditions (R21 Clinical Trial Optional)
• Self-Management for Health in Chronic Conditions (R15 Clinical Trial Not Allowed)
  National Institute of Nursing Research
  National Institute on Aging
    
• Community Partnerships to Advance Research (CPAR) (R01 Clinical Trial Optional)
• Community Partnerships to Advance Research (CPAR) (R21 Clinical Trial Optional)
• Community Partnerships to Advance Research (CPAR) (R15 Clinical Trial Not Allowed)
  National Institute of Nursing Research
    
• Innovative Questions in Symptom Science and Genomics (R15 Clinical Trial Not Allowed)
  National Institute of Nursing Research
   
• Personalized Strategies to Manage Symptoms of Chronic Illness (R15 Clinical Trial Not Allowed)
  National Institute of Nursing Research. 
• Effects of In Utero Alcohol Exposure on Adult Health and Disease (R01 - Clinical Trial Optional)
• Effects of In Utero Alcohol Exposure on Adult Health and Disease (R21 - Clinical Trial Optional)
  National Institute on Alcohol Abuse and Alcoholism
   
• Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp - Clinical Trial Not Allowed)
  National Cancer Institute
  National Center for Advancing Translational Sciences
  National Center for Emerging and Zoonotic Infectious Diseases 
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  National Institute for Occupational Safety and Health
    
• Radiological/Nuclear Medical Countermeasure Product Development Program (SBIR) (R43/R44 Clinical Trial Not Allowed)
  National Institute of Allergy and Infectious Diseases
    
• Early-life Factors and Cancer Development Later in Life (R01 - Clinical Trial Not Allowed)
• Early-life Factors and Cancer Development Later in Life (R03 - Clinical Trial Not Allowed)
• Early-life Factors and Cancer Development Later in Life (R21 - Clinical Trial Not Allowed)
  National Cancer Institute
    
• Research on the Mechanisms and/or Behavioral Outcomes of Multisensory Processing (R01 - Clinical Trial Optional)
  National Institute on Aging
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Neurological Disorders and Stroke
  Office of Behavioral and Social Science Research
    
• Advancing Basic Neurobiology Toward Translation Through Assay Development (R01 Clinical Trials Not Allowed)
  National Institute of Mental Health
    
• Drug Repurposing for Conditions Affecting Neonates and Pregnant Women (R01 - Clinical Trial Optional)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 
    
• Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R21 Clinical Trial Optional )
• Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R01 )
• Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R03 Clinical Trial Optional)
  National Institute on Drug Abuse
  
   
• Discovery of Molecular Targets for Pregnancy-Related/Induced Diseases and Development of Therapeutics to Prevent/Treat These Diseases (R01 - Clinical Trial Optional)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 
    
• Testing Lifespan/Healthspan-Extension Interventions in the Models of Alzheimers Disease (AD/ADRD) (R43/R44 Clinical Trial Not Allowed)
• Testing Lifespan-Healthspan-Extension Interventions in the Models of Alzheimers Disease (AD/ADRD) (R41/R42 Clinical Trial Not Allowed)
  National Institute on Aging
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
    
• Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required)
  National Institute on Aging
    
• Human Cell Biology of Alzheimer's Disease Genetic Variants (R01 - Clinical Trial Not Allowed)
  National Institute on Aging
   
• Sensory and motor system changes as predictors of preclinical Alzheimers disease (R01 - Clinical Trial Not Allowed)
  National Institute on Aging
   
• NEI Collaborative Clinical Vision Research Project: Coordinating Center Grant (UG1 Clinical Trial Required)
• NEI Collaborative Clinical Vision Project: Resource Center Grant (UG1- Clinical Trial Required)
• NEI Collaborative Clinical Vision Research : Chair's Grant (UG1-Clinical Trial Required)
  National Eye Institute
    
• Institutional Training Programs to Advance Translational Research on Alzheimer's Disease and AD Related Dementias (T32 - Clinical Trial Not Allowed)
  National Institute on Aging
    
• NeuroNEXT Clinical Trials (U01 - Clinical Trial Optional)
  National Institute of Neurological Disorders and Stroke
    
• Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)
  National Cancer Institute
  National Institute of Biomedical Imaging and Bioengineering
  National Institute of Diabetes and Digestive and Kidney Diseases
   . 
• NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01- Clinical Trials Optional)
  National Institute on Deafness and Other Communication Disorders
    
• Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01)
  National Institute of Neurological Disorders and Stroke
    
• Basic and Translation Research on Decision Making in Aging and Alzheimer's Disease (R21 - Clinical Trial Optional)
• Basic and Translational Research on Decision Making in Aging and Alzheimer's Disease (R01 - Clinical Trial Optional)
  National Institute on Aging
    
• International Research Scientist Development Award (IRSDA) (K01) - Independent Clinical Trial Not Allowed
• International Research Scientist Development Award (IRSDA) (K01) - Independent Clinical Trial Required
  John E. Fogarty International Center
  National Cancer Institute
    
• Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44) - Clinical Trial Optional
• Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3) - Clinical Trial Optional
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Mental Health
    
• NINDS CREATE Bio Development Track: Preclinical Development for Biotechnology Products and Biologics (U01 - Clinical Trial Optional)
• CREATE Bio Development Track: Preclinical and Early-Phase Clinical Development for Biologics (U44 SBIR- Clinical Trial Optional)
  National Institute of Neurological Disorders and Stroke
    
• NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3) - Clinical Trial Required
  National Institute of Dental and Craniofacial Research
    
• Clinical Validation of a Candidate Biomarker for Neurological Disease (U44 - Clinical Trial Optional)
  National Institute of Neurological Disorders and Stroke
    
• Analytical Validation of a Candidate Biomarker for Neurological Disease (U44 - Clinical Trial Optional)
• Analytical Validation of Candidate Biomarkers for Neurological Disease (U01 Clinical Trial Optional)
  National Institute of Neurological Disorders and Stroke
    
• Partnership for Aging and Cancer Research (U01 - Clinical Trial Not Allowed)
  National Cancer Institute
  National Institute on Aging

Details, including application deadlines, when applicable, are available through the program links above.  To view the full NIH Guide, present and/or past, please visit http://grants1.nih.gov/grants/guide/index.html

Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at 335-2123, or email Linda Meyer at linda-k-meyer@uiowa.edu, Paul Below at paul-below@uiowa.edu or Lynn Hudachek at lynn-hudachek @uiowa.edu